Localizing hyperfunctioning parathyroid tissue: MRI or nuclear study or both?

Clinical Imaging

Volumn 30, Issue 4, 2006, Pages 257-265

  Saeed, Shabana ^a   Yao, Mike ^a   Philip, Binu ^a   Blend, Michael ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Dual phase sestamibi imaging; MRI in hyperparathyroidism patients

Indexed keywords

DUAL-PHASE SESTAMIBI IMAGING; HYPERPARATHYROIDISM; MRI IN HYPERPARATHYROIDISM PATIENTS;

MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PATIENT TREATMENT; STATISTICS; SURGERY;

TISSUE;

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; HYPERPARATHYROIDISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 33745228918     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinimag.2006.02.007     Document Type: Article

References (44)

1. Clark O., and Duh Q. Primary hyperparathyroidism: a surgical perspective. Endocrinol Metab Clin North Am 18 (1989) 701-714
2. Wei J., Burke G., and Mansberger A. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroidism disease using combination Tc-99m-pertechnetate and Tc-99m sestamibi radionuclide scans. Ann Surg 219 (1994) 568
3. Taillefer R. 99m Tc-sestamibi parathyroid scintigraphy. Nucl Med Annu (1995) 51-75
4. Hindié E., Melliere D., Simon D., Perlemuter L., and Galle P. Primary hyperparathyroidism: is technetium 99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery?. J Clin Endocrinol Metab 80 (1995) 302-310
5. Shaha A., LaRosa C., and Jaffe B. Parathyroid localization prior to primary exploration. Am J Surg 166 3 (1993) 289-293
6. Numerow L., Morita E., Clark O., and Higgins C. Persistent/recurrent hyperparathyroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging 5 (1995) 702-708
7. Auffermann W., Gooding G., Okerlund M., et al. Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques. AJR Am J Roentgenol 150 (1988) 1027-1033
8. Stevens S., Chang J., Clark O., Chang P., and Higgins C. Detection of abnormal parathyroid glands in postoperative patients with recurrent hyperparathyroidism: sensitivity of MR imaging. AJR Am J Roentgenol 160 (1993) 607-612
9. Peck W., Higgins C., Fisher M., Ling M., Okerlund M., and Clark O. Hyperparathyroidism: comparison of MR imaging with radionuclide scanning. Radiology 163 (1987) 415-420
10. Flickinger F., Sathyanarayana R., White J., and McWhirt E. MRI in hyperparathyroidism requiring reoperation. Clin Imaging 15 (1991) 210-212
11. Mitchell B., Merrell R., and Kinder B. Localization studies in patients with hyperparathyroidism. Surg Clin North Am 75 (1995) 483-498
12. Coakley A., Kettle A., Wells C., et al. Technetium-99m-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 10 (1989) 791-793
13. Sandrock D., Merino M., Norton J., et al. Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 34 (1993) 24-27
14. Shen W., Sabanci U., Morita E., Siperstein A., Duh Q., and Clark O. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 132 (1997) 969-976
15. McHenry C., Lee K., Saadey J., Neumann D., and Esselstyn C. Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg 183 (1996) 25-30
16. Caixas A., Berna L., Piera J., Rigla M., Matias-Guiu X., Farrerons J., and Puig-Domingo M. Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol (Oxf) 43 5 (1995) 525-530
17. Walgenbach S., Dutkowski P., Andreas J., Gorges R., Bockisch A., and Junginger T. 99mTc-MIBI-scintigraphy before parathyroid surgery?. Zentralbl Chir 124 3 (1999) 214-219
18. De Feo M., Colagrande S., Biagini C., Tonarelli A., and Bisi G. Parathyroid glands: combination of 99mTc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 214 (2000) 393-402
19. Wakamatsu H., Noguchi S., Yamashita H., Yamashita H., Tamura S., et al. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. NM Comm 24 7 (2003) 755-762
20. McBiles M., Lambert A., Cote M., et al. Sestamibi parathyroid imaging. Semin Nucl Med 25 (1995) 221-234
21. Taillefer R., Boucher Y., Potvin C., et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study). J Nucl Med 33 (1992) 1801
22. Fjeld J., Erichsen K., Pfeffer P., et al. Technetium-99m-tetrofosmin for parathyroid imaging: a comparison with sestamibi. J Nucl Med 38 (1997) 831
23. Mordechai L., Irit M., Sorina M., et al. Incremental value of preoperative Tc-99m MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 44 (2003) 904-908
24. Pons F., Torregrosa J., and Fuster D. Biological factors influencing parathyroid localization. Nucl Med Comm 24 (2003) 121-124
25. Kohri K., Ishikawa Y., Kodama M., Katayama Y., Iguchi M., Yachiku S., and Kurita T. Comparison of imaging methods for localization of parathyroid tumors. Am J Surg 164 2 (1992) 140-145
26. Takebayashi S., Hidai H., Chiba T., et al. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 40 (1999) 1792
27. Torregrosa J., Fernandez-Cruz L., Canalejo A., et al. (99m) Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 24 (2000) 1386
28. Chiu M., Kronange J., and Piwnicka-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutilisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 31 (1990) 1646
29. Hung G.-U., Wang S.-J., and Lin W.-Y. Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med 8 (2003) 180-185
30. Kao A., Shiau Y., Tsai S., Wang J., and Ho S. Technetium-99m methoxyisibutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance related protein expression. Eur J Nucl Med 29 (2002) 1012-1015
31. Yanguchi S., Yuchiku S., and Hashimoto H. Relationship between Tc-99m MIBI accumulation and multidrug resistance protein in the parathyroid glands. World J Surg 26 (2002) 29-34
32. Numerow L., Morita E., Clark O., and Higgins C. Persistent/recurrent hyperparathyroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging 5 (1995) 702-708
33. Lee V., Spritzer C., Coleman R., et al. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. AJR Am J Roentgenol 167 (1996) 1555-1562
34. Erdman W., Breslau N., Weinreb J., et al. Noninvasive localization of parathyroid adenomas: a comparison of x-ray computerized tomography, ultrasound, scintigraphy and MRI. Magn Reson Imaging 7 (1989) 187-194
35. Giron J., Ouhayoun E., Dahan M., et al. Imaging of hyperparathyroidism: US, CT, MRI and MIBI scintigraphy. Eur J Radiol 21 (1996) 167-173
36. McDermott V., Fernandez R., Meakem T., et al. Preoperative MR imaging in hyperparathyroidism: results and factors affecting parathyroid detection. AJR Am J Roentgenol 166 (1996) 705-710
37. Hewin D., Brammar T., Kabala J., and Farndon J. Role of preoperative localization in the management of primary hyperparathyroidism. Br J Surg 84 10 (1997) 1377-1380
38. Wei J., Burke G., and Mansberger A. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 112 (1992) 1111
39. Blake G., Percival R., and Kanis J. Thallium-pertechnetate scintigraphy: a quantitative comparison between adenomatous, and hyperplastic parathyroid glands. Eur J Nucl Med 12 (1986) 31-36
40. Jeanguillaume C., Urena P., Hindie E., et al. Secondary hyperparathyroidism: detection with I-123-Tc-99m sestamibi subtraction scintigraphy versus US. Radiology 207 (1998) 207-213
41. Chen E., Elisa M., Mishkin F., et al. Parathyroid hyperplasia may be missed by double phase Tc-99m sestamibi scintigraphy alone. Clin Nucl Med (1997) 222-226
42. Leonie G., William B., and Eugene M. Dual phase Tc-99m sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism. J Nucl Med Technol 30 4 (2002) 179-184
43. Fayet P., Hoeffel C., Fulla Y., et al. Technetium-99m sestamibi scintigraphy, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism. Br J Radiol 70 (1997) 459-464
44. Piga M., Bolasco P., Satta L., et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 37 (1996) 465-569